A clinical trial for early detection of cervical cancer using optical techniques

Non-invasive detection of cervical malignancies using diffuse reflectance imaging and fluorescence/reflectance point monitoring techniques

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2014/02/004424

Enrollment

Registered

2014-02-20

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients with suspected cervical cancer/ precancerous lesions

Interventions

Intervention1: Single arm, non-randomized trial: non-randomized trial Intervention2: Cervical cancer detection: Diffuse reflectance imaging and fluorescence and diffuse reflectance point monitoring te

Eligibility

Inclusion criteria

Inclusion criteria: Patients with positive pap smear reports Patients referred for colposcopic examination Patients with any kind of clinically suspecting lesions in the uterine cervix

Exclusion criteria

Exclusion criteria: Patient refusal Patients with transmittable diseases

Design outcomes

Primary

Measure	Time frame
Identification of the malignant site for optimal biopsy and histology; and Reduction of false negativesTimepoint: First arrival at OP clinic	—

Secondary

Measure	Time frame
Reduced trauma, morbidity; and Real-time, Noninvasive diagnosisTimepoint: At the first visit to Clinic	—

Countries

India

Contacts

Public ContactDr N Subhash

Vinvish Technologies

subhashnarayanan@gmail.com9400497015

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026